294As the General Court, in essence, pointed out in paragraph 305 of the judgment under appeal, it is therefore necessary, in order to determine whether an agreement may be characterised as a restriction of competition by object, not to analyse each of its clauses separately, but to assess whether that agreement, taken as a whole, reveals a degree of economic harm to the proper functioning of competition in the market concerned which justifies such characterisation. By reason of the close links between the non-challenge, non-marketing and exclusive supply clauses of the Teva agreement, it was therefore essential to examine those clauses as forming a whole.